Skip to main content

Next-Generation Vaccines Eradicating Chronic and Infectious Diseases


The growing prevalence of chronic and infectious disorders such as cancer, and diabetes, globally has emerged as the biggest concerns that the medical industry faces today. There have been continuous attempts to develop improved treatment procedures for such diseases.
Vaccines have been one of the most effective methods for the treatment and prevention of diseases. The invention of DNA, recombinant, and cancer vaccines, and advancements in the platform for vaccine delivery have transformed the conventional therapeutic and preventive vaccines and are playing an important role in the treatment of such chronic diseases.
At present, the vaccine market is in its growing stage, however as per the market intelligence report published by BIS Research titled “Global Vaccine Market – Analysis and Forecast (2018 – 2028),” the vaccine market is anticipated to witness tremendous growth at 11.0% during the forecast period, 2018 – 2028 and generate $103.57 billion in the revenue by 2028.
This high growth of the market can be attributed to the increasing incidences of chronic diseases, growing adoption of vaccines across developed as well as developing countries, and the invention of advanced techniques and technologies.  Amongst the long list of advantages of vaccines, the reduced healthcare cost and improved life expectancy rate are their major benefits.
Several leading pharmaceutical companies are venturing in the market, some of these include Abbott Laboratories, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Merck & Company Inc., and Madison Vaccines Incorporated.
The report published by BIS Research discusses the vaccine market under different segments on the basis of type, disease type, and region. Under the vaccine type, there are subunit and conjugate, live attenuated, inactivated, recombinant, toxoid, and next-generation vaccines. Moreover, the disease type segment includes cancer, hepatitis, rotavirus, varicella, and influenza, among others.
Under the region segment, the report analyzes the market for North America, Europe, Asia-Pacific, Latin America, and Middle East Africa. Amongst these, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period.
With technological advancements in the medical industry, vaccines for multiple cancers such as gastric, ovarian, melanoma, and prostate cancer have already been developed and several companies at present are focusing to develop next-generation vaccines. The global vaccine market in the coming years is expected to evolve and undergo various developments and advancements.

Comments

Popular posts from this blog

Understanding How the Human Centric Lighting Market is Segmented

Lighting plays a significant role in the lives of people, it has the potential to bring about positive changes in people’s behaviour. In the year 1989, a research was carried out and it proved that natural daylight can trigger the production of melatonin and serotonin, two of the most important hormones in the human body. These two hormones are responsible for inducing peaceful sleep and happiness in people. This led to the research and development in the field of human centric lighting (HCL). According to a report published by the BIS Research , the HCL market is expected to grow at a CAGR of 37.2% and 35.2% both in terms of volume and value during the forecast period (2018 – 2024). The HCL is segmented by the component, end-user and by region. Request the Sample: Human Centric Lighting Market The human centric lighting market can be further segmented by component, type, end-users, and region. The components or the controls are further segmented as microprocessors & microco...

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...

Global Surgical Robotics Market: Analysis and Forecast, 2018-2025

Global Surgical Robotics Market: Focus on Products and Services (Surgical Systems, Instruments & Accessories, and Services & Maintenance), Applications, End Users, and Competitive Landscape: Analysis and Forecast, 2018-2025. Rising incidences of colorectal cancer, neurological disorders, interventional cardiology disorders and gynecological diseases, growing geriatric population, and active participation of the government and the industry players in the technological advancement in the field of computer assisted robotic surgeries have boosted the overall growth of this market. Another factor which significantly contributes to the revenue generation of a company is the recurring sale of equipment and accessories of a surgical system. The surgical robotics vendors generate revenue through one time sale of the surgical system and generate the recurring  revenue from the sale of equipment and accessory products and maintenance services used in the surgical system. A...